Wednesday, August 26, 2026

Commodities & Mining

2 articles

Alamos Gold targets 2028 completion for Island Gold District Expansion

Alamos Gold targets 2028 completion for Island Gold District Expansion

Alamos Gold expects to complete its Island Gold District Expansion by December 2028, marking a major capacity buildout at one of Canada's highest-grade gold operations. The project signals continued investment in production growth as the company recently increased its dividend 60%, reflecting confidence in cash flow generation from existing and future operations.

ViaNews Editorial Team (Markets)
SPAC Redemption Risk Casts Shadow Over Mkango Rare Earths' Critical Mining Ambitions

SPAC Redemption Risk Casts Shadow Over Mkango Rare Earths' Critical Mining Ambitions

Mkango Rare Earths Limited faces a potentially catastrophic funding gap as its SPAC merger structure through Capitol Federal (CPTK) leaves the company vulnerable to high shareholder redemptions that could drain the capital needed to advance the Songwe Hill rare earths project in Malawi and a planned separation facility in Pulawy, Poland. Analysts assign a high likelihood to this scenario, raising serious questions about the viability of the company's development timeline and its position in the

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com